All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF521 | Anti-Human IL13RA2 (XW-521) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-521 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF522 | Anti-Human IL13RA2 (XW-522) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-522 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF523 | Anti-Human IL13RA2 (XW-523) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-523 | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF524 | Anti-Human IL13RA2 (XW-524) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-524 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF525 | Anti-Mouse IL13RA2 (XW-525) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-525 | Rabbit | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1441 | Anti-Human IL13RA2 (XW-521) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-521 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1442 | Anti-Human IL13RA2 (XW-522) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-522 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1443 | Anti-Human IL13RA2 (XW-523) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-523 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1444 | Anti-Human IL13RA2 (XW-524) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-524 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1445 | Anti-Mouse IL13RA2 (XW-525) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-525 | Rabbit | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2361 | Anti-Human IL13RA2 (XW-521) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-521 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2362 | Anti-Human IL13RA2 (XW-522) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-522 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2363 | Anti-Human IL13RA2 (XW-523) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-523 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0123-ZP516 | Anti-IL13RA2 (SI320DS) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | SI320DS | Rabbit | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP255 | Anti-IL13RA2 (m47 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | m47 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP256 | Anti-IL13RA2 (scFv47 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | scFv47 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP257 | Anti-IL13RA2 (mu08 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | mu08 | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP258 | Anti-IL13RA2 (FMMU-IL-13R alpha 2-7 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | FMMU-IL-13R alpha 2-7 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP516 | Anti-IL13RA2 (SI320DS scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | SI320DS | Rabbit | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0923-LX34 | Anti-hIL13RA2 (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-3 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION